Lingzhilactones from Ganoderma lingzhi ameliorate adriamycin-induced nephropathy in mice
Yan, Yong-Ming; Wang, Xin-Long; Zhou, Li-Li; Zhou, Feng-Jiao; Li, Rong; Tian, Yuan; Zuo, Zhi-Li; Fang, Ping; Chung, Arthur C. K.; Hou, Fan-Fan; Cheng, Yong-Xian
2015-12-24
发表期刊JOURNAL OF ETHNOPHARMACOLOGY
卷号176页码:385-393
摘要Ethnopharmacological relevance: Several Ganoderma fungi are well-known for their medical uses to treat cancer, insomnia and kidney disease in East Asia. Triperpenoids and polysaccharides have been considered for a long time to be the major active components of the genus Ganoderma. The present study is to examine the effects of lingzhilactones from G. lingzhi on adriamycin-induced nephropathy in mice.
关键词Ganoderma Lingzhi Ganodermataceae Meroterpenoids Chronic Kidney Disease Reactive Oxygen Species Nrf2
DOI10.1016/j.jep.2015.11.024
收录类别SCI
语种英语
WOS记录号WOS:000367106600035
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/25337
专题植物化学与西部植物资源持续利用国家重点实验室
推荐引用方式
GB/T 7714
Yan, Yong-Ming,Wang, Xin-Long,Zhou, Li-Li,et al. Lingzhilactones from Ganoderma lingzhi ameliorate adriamycin-induced nephropathy in mice[J]. JOURNAL OF ETHNOPHARMACOLOGY,2015,176:385-393.
APA Yan, Yong-Ming.,Wang, Xin-Long.,Zhou, Li-Li.,Zhou, Feng-Jiao.,Li, Rong.,...&Cheng, Yong-Xian.(2015).Lingzhilactones from Ganoderma lingzhi ameliorate adriamycin-induced nephropathy in mice.JOURNAL OF ETHNOPHARMACOLOGY,176,385-393.
MLA Yan, Yong-Ming,et al."Lingzhilactones from Ganoderma lingzhi ameliorate adriamycin-induced nephropathy in mice".JOURNAL OF ETHNOPHARMACOLOGY 176(2015):385-393.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
1-s2.0-S037887411530(8566KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yan, Yong-Ming]的文章
[Wang, Xin-Long]的文章
[Zhou, Li-Li]的文章
百度学术
百度学术中相似的文章
[Yan, Yong-Ming]的文章
[Wang, Xin-Long]的文章
[Zhou, Li-Li]的文章
必应学术
必应学术中相似的文章
[Yan, Yong-Ming]的文章
[Wang, Xin-Long]的文章
[Zhou, Li-Li]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 1-s2.0-S0378874115302178-main.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。